SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

Proceedings of the National Academy of Sciences of the United States of America
Julie M StrizkiBahige M Baroudy

Abstract

We describe here the identification and properties of SCH-C (SCH 351125), a small molecule inhibitor of HIV-1 entry via the CCR5 coreceptor. SCH-C, an oxime-piperidine compound, is a specific CCR5 antagonist as determined in multiple receptor binding and signal transduction assays. This compound specifically inhibits HIV-1 infection mediated by CCR5 in U-87 astroglioma cells but has no effect on infection of CXCR4-expressing cells. SCH-C has broad and potent antiviral activity in vitro against primary HIV-1 isolates that use CCR5 as their entry coreceptor, with mean 50% inhibitory concentrations ranging between 0.4 and 9 nM. Moreover, SCH-C strongly inhibits the replication of an R5-using HIV-1 isolate in SCID-hu Thy/Liv mice. SCH-C has a favorable pharmacokinetic profile in rodents and primates with an oral bioavailability of 50-60% and a serum half-life of 5-6 h. On the basis of its novel mechanism of action, potent antiviral activity, and in vivo pharmacokinetic profile, SCH-C is a promising new candidate for therapeutic intervention of HIV infection.

References

Aug 1, 1996·Seminars in Immunology·J M McCune
Feb 17, 1997·The Journal of Experimental Medicine·R I ConnorN R Landau
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·M BabaM Fujino
Jul 8, 1999·Nature Medicine·N L Michael, J P Moore
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·T DragicJ P Moore
Oct 19, 2000·The Journal of Cell Biology·R W Doms, J P Moore
Jun 20, 2001·Nature Reviews. Molecular Cell Biology·J P Moore, M Stevenson

❮ Previous
Next ❯

Citations

Oct 9, 2002·Medicinal Research Reviews·Erik De Clercq
Dec 14, 2004·Applied Microbiology and Biotechnology·Julia MagdenTero Ahola
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Paul J PetersPaul R Clapham
Jan 18, 2013·Archives of Pharmacal Research·Changdev G GadheSeung Joo Cho
Jul 12, 1990·Biochimica Et Biophysica Acta·K OhyamaA H Kang
Feb 15, 2003·Biochimica Et Biophysica Acta·David DrewJan-Willem L de Gier
Jan 16, 2003·Immunology Letters·Theodore C Pierson, Robert W Doms
Jul 23, 2003·Trends in Pharmacological Sciences·Terry Kenakin
Oct 10, 2002·Bioorganic & Medicinal Chemistry Letters·Vinod R HegdeC G Naik
Mar 18, 2003·Bioorganic & Medicinal Chemistry Letters·Anandan PalaniNiya Dan
Jun 6, 2003·Bioorganic & Medicinal Chemistry·Wieslaw KazmierskiTerry Kenakin
May 3, 2003·Methods : a Companion to Methods in Enzymology·Richard Horuk
Aug 28, 2003·Current Opinion in Chemical Biology·Pantea Houshmand, Albert Zlotnik
Feb 26, 2003·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Louise A Cooley, Sharon R Lewin
Sep 27, 2002·Current Opinion in Pharmacology·Bryan M O'Hara, William C Olson
Sep 27, 2002·Current Opinion in Pharmacology·Mark J BisconeRobert W Doms
Jan 27, 2009·Journal of Chemical Information and Modeling·Guo LiYan Zhang
Sep 11, 2007·The Journal of Antibiotics·Shu-Wei YangMin Chu
Jul 18, 2002·Nature Reviews. Drug Discovery·Matthias K Schwarz, Timothy N C Wells
Mar 26, 2004·Nature Reviews. Microbiology·Robin J Shattock, John P Moore
May 30, 2003·The New England Journal of Medicine·J Michael Kilby, Joseph J Eron
Apr 12, 2003·AIDS Research and Human Retroviruses·Thomas J KetasJohn P Moore
Jan 9, 2010·AIDS Research and Human Retroviruses·John C TiltonRobert W Doms
Mar 8, 2011·AIDS Research and Human Retroviruses·Fang Yu WangTao Teng
Jun 15, 2007·Antioxidants & Redox Signaling·Emmanuel FenouilletIan M Jones
Jan 5, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Paolo LussoVincenzo Pavone
Oct 28, 2009·Antimicrobial Agents and Chemotherapy·Dong XieHe Jiang
Feb 24, 2011·Antimicrobial Agents and Chemotherapy·Vanessa PirroneFred C Krebs
Nov 23, 2006·Antimicrobial Agents and Chemotherapy·Masanori BabaKatsunori Takashima
Mar 27, 2013·Antimicrobial Agents and Chemotherapy·Michael A LobritzEric J Arts

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.